Saro Armenian
Overview
Explore the profile of Saro Armenian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blaes A, Nohria A, Armenian S, Bergom C, Thavendiranathan P, Barac A, et al.
JACC CardioOncol
. 2025 Feb;
7(1):1-19.
PMID: 39896126
Cancer survivors, particularly those treated with anthracyclines and chest radiation, face an elevated risk of cancer therapy-related cardiovascular toxicity. These complications affect not only physical health, but also life expectancy....
2.
Sanft T, Day A, Goldman M, Ansbaugh S, Armenian S, Baker K, et al.
J Natl Compr Canc Netw
. 2024 Dec;
22(10):648-658.
PMID: 39689426
The NCCN Guidelines for Survivorship include recommendations for screening, evaluation, and treatment of psychosocial and physical problems resulting from adult-onset cancer and its treatment. They also include recommendations to promote...
3.
Fanaroff A, Orr J, Anucha C, Kim E, Rareshide C, Echevarria M, et al.
Am Heart J
. 2024 Nov;
280:42-51.
PMID: 39505121
Background: Survivors of breast and prostate cancer, especially those that are Black and/or Hispanic, are at high risk for cardiovascular events. Physical activity can reduce the risk of cardiovascular events...
4.
Lin C, Narayan H, Trovillion E, Armenian S, Alejandro L, Kuo D
J Pediatr Pharmacol Ther
. 2024 Oct;
29(5):475-481.
PMID: 39411421
Objective: Anthracycline chemotherapy agents have significant dose-dependent cardiotoxic effects. -Carnitine, a non-essential amino acid, is involved in long chain fatty acid oxidation, and carnitine deficiency can result in cardiomyopathy and...
5.
Edwards L, Yang C, Sharma S, Chen Z, Gorantla L, Joshi S, et al.
Cardiooncology
. 2024 Oct;
10(1):66.
PMID: 39385257
Background: Despite routine echocardiographic surveillance for childhood cancer survivors, the ability to predict cardiomyopathy risk in individual patients is limited. We explored the feasibility and optimal processes for machine learning-enhanced...
6.
Thiruvengadam S, Mei M, Chen L, Puverel S, Chen R, Popplewell L, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Jul;
24(10):724-731.e1.
PMID: 39043499
Introduction: BV is an antibody-drug conjugate directed against CD30 and is safe and effective in relapsed/refractory (R/R) Hodgkin lymphoma (HL). Most patients with r/r cHL respond well to BV monotherapy;...
7.
Bostany G, Chen Y, Francisco L, Dai C, Meng Q, Sparks J, et al.
J Clin Oncol
. 2024 Jun;
43(1):32-45.
PMID: 38833638
Purpose: Cardiac dysfunction is the leading cause of mortality among 10-year breast cancer survivors. Limited information regarding long-term risks of cardiac dysfunction after cardiotoxic therapy (anthracyclines, trastuzumab/pertuzumab, radiation) has precluded...
8.
Mei M, Tsai N, Palmer J, Armenian S, Chen R, Rosen S, et al.
Clin Lymphoma Myeloma Leuk
. 2024 May;
24(8):537-542.
PMID: 38693037
Introduction: Brentuximab vedotin (BV) is an antibody-drug conjugate that delivers monomethyl auristatin E (MMAE) to CD30+ cells and is safe and effective in relapsed/refractory (r/r) Hodgkin lymphoma (HL). Although most...
9.
Romero S, Au L, Flores-Ortega R, Helsten T, Palomino H, Kaiser B, et al.
Contemp Clin Trials
. 2024 Apr;
141:107537.
PMID: 38614445
Introduction: Children, adolescent, and young adult cancer survivors experience overall increased risks of infertility that are preventable through effective fertility preservation services prior to starting cancer treatment. Oncofertility care is...
10.
Mertens L, Singh G, Armenian S, Chen M, Dorfman A, Garg R, et al.
J Am Soc Echocardiogr
. 2023 Dec;
36(12):1227-1253.
PMID: 38043984
No abstract available.